Cowen and Company’s Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share APGB.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-84,739
Closed -$6.65K 757
2023
Q3
$6.65K Sell
84,739
-17,461
-17% -$2.08K ﹤0.01% 500
2023
Q2
$12.5K Buy
102,200
+76,200
+293% +$9.83K ﹤0.01% 376
2023
Q1
$2.54K Buy
+26,000
New +$4.12K ﹤0.01% 510
2021
Q4
Sell
-42,403
Closed -$39K 804
2021
Q3
$39K Buy
+42,403
New +$46.8K ﹤0.01% 409

Cowen and Company's APGB.WS Position: Q4 2023 in Review

Cowen and Company sold out of Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share (APGB.WS) in Q4 2023, closing a stake of 84,739 shares — an estimated $6.65K sold.

Cowen and Company first reported a position in APGB.WS in Q3 2021 and held it in 4 quarters. The position peaked at $39K in Q3 2021. 0 funds tracked by Wall St. Rank hold APGB.WS as of Q4 2023.

  • Cowen and Company reported no remaining Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share position as of Q4 2023 after selling out during the quarter.
  • Cowen and Company sold 84,739 Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share shares in Q4 2023, an estimated $6.65K.
  • Cowen and Company first reported a position in Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share in Q3 2021 and held it in 4 quarters.
  • Cowen and Company's Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share position peaked at $39K in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share as of Q4 2023.

Based on Cowen and Company's 13F filing for Q4 2023, filed 8 Feb 2024.